PUBLICATIONS on the DTSQ
Clare Bradley PhD
Professor of Health Psychology
Royal Holloway, University of London
Egham, Surrey, TW20 0EX
Bradley C (1994) The
Diabetes Treatment Satisfaction Questionnaire: DTSQ. In Bradley C (Ed) (1994) Handbook of Psychology and Diabetes: a guide
to psychological measurement in diabetes research and practice. Chur,
Switzerland: Harwood Academic Publishers.
Bradley C and Lewis
KS (1990) Measures of psychological well-being and treatment satisfaction
developed from the responses of people with tablet-treated diabetes. Diabetic Medicine 7, 445-451.
Bradley C and
Speight J (2002) Patient perceptions of diabetes and diabetes therapy:
assessing quality of life. Diabetes
Metabolism Research and Reviews 18: S64-S69.
Current Change Version Articles
Bradley C (1999) The Diabetes Treatment
Satisfaction Questionnaire (DTSQ): change version for use alongside status
version provides appropriate solution where ceiling effects occur. Diabetes Care 22, 3, 530-2.
Howorka K, Pumprla J, Schlusche C,
Wagner-Nosiska D, Schabmann A and Bradley C (2000) Dealing with ceiling
baseline treatment satisfaction level in patients with diabetes under flexible,
functional insulin treatment: assessment of improvements in treatment
satisfaction with a new insulin analogue.
Quality of Life Research 9: 915-930.
Bradley C, Plowright R, Stewart J and
Witthaus E (2000) Diabetes Treatment Satisfaction Questionnaire (change) in
English and German evaluated in insulin glargine trials. Diabetologia 43, suppl
1, A196.
Early Change Version Article (now
superseded)
Lewis KS, Bradley C, Knight G, Boulton
AJM and Ward JD (1988) A measure of treatment satisfaction designed
specifically for people with insulin-dependent diabetes. Diabetic
Medicine 5, 235-242.
Ishii H, Bradley C, Riazi A, Barendse S
and Yamamoto T (2000) The Japanese Version of the Diabetes Treatment
Satisfaction Questionnaire (DTSQ): translation and clinical evaluation. Journal
of Clinical and Experimental Medicine 192,
7, 809-814.
(A Japanese Journal publishing
in Japanese).
Witthaus E,
Stewart J and Bradley C (2001) Treatment satisfaction and psychological
well-being with insulin glargine compared with NPH in patients with Type 1
diabetes. Diabetic Medicine 18, 619-625.
Plowright R, Witthaus E and Bradley C
(2000) Psychometric evaluation of Diabetes Treatment Satisfaction Questionnaire
in 8 languages. Proceedings of the
British Psychological Society 8
(2) 43. (Full paper submitted for publication).
Howorka K et al (2000) referenced above.
(Validating German DTSQs and c).
Wredling R, Stalhammar J, Adamson U,
Berne C, Larsson Y and Ostman J (1995) Well-being and treatment satisfaction in
adults with diabetes: A Swedish population-based study. Quality of Life Research 4,
515-522.
Pouwer F, Snoek FJ, van der Ploeg HM,
Heine RJ and Brand AN (1998) A comparison of the standard and the computerized
versions of the Well-Being Questionnaire (WBQ) and the Diabetes Treatment
Satisfaction Questionnaire (DTSQ). Quality
of Life Research 7 (1), 33-38.
Other
papers, letters and abstracts
Bradley C (1999) On calculating
treatment satisfaction and Pfützner. Diabetes
Care 22, 10, 1760.
Bradley C and Gamsu DS for the
psychological well-being working group of the WHO/IDF St. Vincent Declaration
Action Programme for Diabetes (1994). Guidelines for encouraging psychological
well-being: Report of a working group of the World Health Organisation Regional
Office for Europe and International Diabetes Federation European Region St.
Vincent Declaration Action Programme for Diabetes. Diabetic Medicine, 11, 510-516.
Bradley C, Silvestre L and Witthaus E.
Improved treatment satisfaction and perceived metabolic control with insulin
glargine, regardless of whether injected before breakfast, dinner or bedtime,
in patients with Type 1 diabetes. Diabetes
52, suppl 1, A456.
Bradley C, Witthaus E and Stewart J
(1999) Treatment satisfaction and psychological well-being in patients with
type 1 diabetes, treated with a new long-acting insulin, insulin glargine. Diabetes 48, suppl 1, A1547.
Cooper HC and Lorains JW (1998)
Managing poor control in Type 2 diabetes. Practical
Diabetes International 15 (6),
173-177.
DAFNE Study Group*
(2002) Training in flexible, intensive insulin management to enable dietary
freedom in people with type 1 diabetes: the dose adjustment for normal eating
(DAFNE) randomised controlled trial. British
Medical Journal, 325, 746-749
(full 6 page version of paper published on BMJ website http://bmj.com/cgi/content/full/325/7367/746).
*Amiel S, Beveridge S, Bradley C,
Gianfrancesco C, Heller S, James P, McKeown N, Newton D, Newton L, Oliver L,
Reid H, Roberts S, Robson S, Rollington J, Scott V, Speight J, Taylor C,
Thompson G, Turner E & Wright F.
Gale EAM for the UK
Trial Group: Alban-Davies H, Bilous RW, Bradley C, et al (2000) A randomized,
controlled trial comparing insulin lispro with human soluble insulin in
patients with Type 1 diabetes on intensified insulin therapy. Diabetic Medicine 17, 3, 209-214.
Hirsch A, Bartholomae C and Volmer T
(2000) Dimensions of quality of life in people with non-insulin-dependent
diabetes. Quality of Life Research 9 (2), 207-218.
Home PD, Lindholm A and Riis A
(2000). Insulin aspart vs. human insulin
in the management of long-term blood glucose control in Type 1 diabetes
mellitus: a randomised control trial. Diabetic
Medicine 17 (11), 762-770.
Janes JM, Bradley C
and Rees A (1997) Preferences for, and improvements in aspects of quality of
life (QoL) with insulin lispro in a multiple injection regimen. Diabetologia 40, suppl 1, A353.
Jennings AM, Lewis KS, Murdoch S,
Talbot JF, Bradley C and Ward JD (1991) Randomized trial comparing continuous
subcutaneous insulin infusion with conventional insulin therapy in type II
diabetic patients poorly controlled with sulphonylureas. Diabetes Care 14,
738-744.
Johansson UB, Wredling RAM, Adamson UCK
and Lins PES (1999) A randomised study evaluating the effects of cisapride on
glucose variability and quality of life parameters in insulin-dependent
diabetes mellitus patients. Diabetes
& Metabolism (Paris) 25,
314-319.
Johansson UB, Adamson UCK & Lins
PES and Wredling RAM (2000) Improved blood glucose variability, HbA1c
and less insulin requirement in IDDM patients using insulin lispro in
CSII. The Swedish multicenter lispro
insulin study. Diabetes & Metabolism
(Paris) 26 (3), 192-196.
Kinmonth A-L, Woodcock A, Griffin S,
Spiegel N and Campbell MJ (1998) Randomised control trial of patient-centred
care in general practice: impact on current well-being and future disease risk.
British Medical Journal 317, 1202-1208.
Menzel R, Chlup R, Jutzi E and Hildman
W (1990) “Catheter-Pens” – an alternative to insulin pump treatment? Experimental Clinical Endocrinology 95, 157-164.
Petterson T, Lee P, Hollis S, Young B,
Newton P, and Dornan T (1998) Well-being and treatment satisfaction in older
people with diabetes. Diabetes Care 21, 930-935.
Renner R, Pfutzner A, Trautmann M,
Harzer O, Sauter K and Landgraf R on behalf of the German Humalog-CSII Study
Group (1999) Use of insulin lispro in continuous subcutaneous insulin infusion
treatment. Diabetes Care 22, 784-788.
[Note: error in reporting of DTSQ
scores (all 8 items in DTSQ combined instead of 6 items that should form the treatment
satisfaction score) pointed out by Bradley C (1999) On Calculating Treatment
Satisfaction. Diabetes Care 22, 10, 1760, and corrected figures
supplied by Pfützner A (1999) Response to Bradley. Diabetes Care 22, 10,
1760. Letters also discuss substantial and interesting carryover effects
observed when patients switch back from Lispro to standard soluble in crossover
trials and show marked reductions in satisfaction with standard soluble]
Taylor R, Foster B, Kyne-Grzebalski D
and Vanderpump M (1994) Insulin regimens for the non-insulin dependent: impact
on diurnal metabolic state and quality of life. Diabetic Medicine 11,
551-557.
Ward, J, Lin M, Heron, G
and Lajoie V (1997) Comprehensive audit of quality-of-care and quality-of-life
for patients with diabetes. Journal of
Quality in Clinical Practice 17, 91-100
[Note: the authors have
misinterpreted the scale (and the patients’ responses to it) for the perceived
frequency of hyper- and hypoglycaemia items: it is not actual number of
episodes but a more general indication of frequency that these items measure]
Witthaus E, Stewart J and Bradley C (2000) Improved psychological outcomes after initiation of insulin treatment in patients with Type II diabetes. Diabetologia 43, suppl 1, A205.
Wredling R, Adamson L, Berne C, Dahlen
M, Ostman J, Larsson Y and Stalhammar J (1993) Quality of life among a
representative sample of people with diabetes mellitus in Sweden. Diabetes, Nutrition and Metabolism 6, 393-395.
Adaptations
of the DTSQ for other conditions
HIV
Woodcock A and
Bradley C (2001) Validation of the HIV Treatment Satisfaction Questionnaire
(HIVTSQ). Quality of Life Research 10, 517-531.
Renal failure
Barendse SM and Bradley C (2000) The
Renal Treatment Satisfaction Questionnaire (RTSQ). A condition-specific measure
of satisfaction with treatment for end-stage renal failure. Peritoneal Dialysis International 20, suppl 1, S82.
Diabetic Retinopathy
Woodcock A, Bradley C, Plowright R,
Kennedy-Martin T and Hirsch A (2003) Patient experiences of treatment for
diabetic retinopathy: development of a retinopathy-specific treatment
satisfaction questionnaire. Diabetic
Medicine 20, suppl 2, P213.
Genital Herpes
Taback N and Bradley C (2000) Validation
of the Genital Herpes Treatment Satisfaction Questionnaire (GHerpTSQ) in status
and change versions. Quality of Life
Research 9 (3) 332.